Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Atomic AI combines machine learning with structural biology to enable the design of RNA-targeted small molecules and RNA-based therapeutics.
Perceptive specializes in the design, development, and manufacturing of medical devices for the dentistry industry.
Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.
General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine.
March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.
Flawless develops TrueSync, the first artificial intelligence-based solution for creating lip-synchronized visualizations in many languages.
Starling develops predictive technology to identify chronic illnesses earlier.
Unnatural Products is a biotech company that focuses on unlocking macrocyclic peptides to create drug therapies.
Lila Sciences creates a scientific superintelligence platform and autonomous labs for life sciences, chemistry, and materials science.
Ignota Labs recognizes that safety errors during the drug discovery process.
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develops precision nanomedicines for ophthalmology diseases.
Ozlo Sleep is a science-driven sleep and audio technology company that simplifies sleep rituals without the use of medication.
PathPresenter is a global image-sharing platform for pathology.
Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.
Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health
Lapsi Health is a Medical Technology company developing Digital Biomarkers from medical sound analytics.
Generate Biomedicines is a biotech company that combines biology, machine learning, and biological engineering to create biomedicines.
Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.
Proxima Bio develops programmable medicines that modulate protein interactions to address disease processes.
Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.
Modi Ventures has invested in 37 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Modi Ventures's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Life Science, Machine Learning. The firm invests across 23 different industry categories.
Among tracked funding rounds, Lila Sciences received $200.0M in a Seed round. Modi Ventures's total known invested capital is $1.0B.
Modi Ventures's average investment size is $28.2M across its portfolio of 37 companies.
Recent Modi Ventures portfolio additions include Atomic AI, Perceptive, Latus Bio, General Proximity, March Biosciences. These companies were founded in 2020 or later.